I think what we have seen today is the result of poor communication from management to shareholders. OK, so AGX would benefit from this new technology for the monitoring of Thromboview.......great......but how about adding some more detail to this example by attaching some numbers to it?! If AGX used this technology what would be the cost and other savings to the company? How much would CCP receive as the supplier? Can this revenue be extrapolated to give shareholders some sort of an idea if this is a potentially profitable business? Can't find anything about CCP on the internet............
I think what we have seen today is the result of poor...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.949M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 34836742 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 7730060 | 9 |
View Market Depth
| Last trade - 16.21pm 29/07/2025 (20 minute delay) ? |
| CT1 (ASX) Chart |
Day chart unavailable